109 related articles for article (PubMed ID: 11482910)
21. Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease.
Holub MC; Makó E; Dévay T; Dank M; Szalai C; Fenyvesi A; Falus A
Scand J Gastroenterol Suppl; 1998; 228():47-50. PubMed ID: 9867112
[TBL] [Abstract][Full Text] [Related]
22. [Construction of membrane-anchored interleukin-6 receptor beta subunit mutant and its effect on IL-6 signal transduction].
Yang Z; Ni C; Shen B; Wang J; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):632-5. PubMed ID: 11877037
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells.
Bosze S; Hudecz F; Igaz P; Ortutay Z; Csík G; Falus A; Tóth S
Biol Chem; 2003 Mar; 384(3):409-21. PubMed ID: 12715892
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro.
Derfalvi B; Igaz P; Fulop KA; Szalai C; Falus A
Cell Biol Int; 2000; 24(2):109-14. PubMed ID: 10772770
[TBL] [Abstract][Full Text] [Related]
25. In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD.
Memoli B; Grandaliano G; Soccio M; Postiglione L; Guida B; Bisesti V; Esposito P; Procino A; Marrone D; Michael A; Andreucci M; Schena FP; Pertosa G
J Am Soc Nephrol; 2005 Apr; 16(4):1099-107. PubMed ID: 15716332
[TBL] [Abstract][Full Text] [Related]
26. No inhibition of IL-27 signaling by soluble gp130.
Scheller J; Schuster B; Hölscher C; Yoshimoto T; Rose-John S
Biochem Biophys Res Commun; 2005 Jan; 326(4):724-8. PubMed ID: 15607729
[TBL] [Abstract][Full Text] [Related]
27. [Antisense oligonucleotide of rat gp130 blocked the inhibitory effect of rhIL-6 on proliferation of the rat acute myeloid leukemia cell line R2 in vitro cultures].
Ren YF; Feng MC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):27-30. PubMed ID: 12513832
[TBL] [Abstract][Full Text] [Related]
28. Endotoxemia enhances expression of the signaling receptor (GP130) on protein and molecular level.
Marsik C; Halama T; Cardona F; Schlifke I; Mittermayer F; Jilma B
Clin Immunol; 2005 Mar; 114(3):293-8. PubMed ID: 15721840
[TBL] [Abstract][Full Text] [Related]
29. Signal transducer and activator of transcription STAT3 plays a major role in gp130-mediated acute phase protein gene activation.
May P; Schniertshauer U; Gerhartz C; Horn F; Heinrich PC
Acta Biochim Pol; 2003; 50(3):595-601. PubMed ID: 14515142
[TBL] [Abstract][Full Text] [Related]
30. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
Yoshida S; Harada T; Iwabe T; Taniguchi F; Mitsunari M; Yamauchi N; Deura I; Horie S; Terakawa N
Hum Reprod; 2004 Aug; 19(8):1821-5. PubMed ID: 15166129
[TBL] [Abstract][Full Text] [Related]
31. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
[TBL] [Abstract][Full Text] [Related]
32. Interleukine-6 (IL-6) synthesis and gp130 expression by human pericardium.
Menet E; Corbi P; Ancey C; Morel F; Delwail A; Garcia M; Osta AM; Wijdenes J; Potreau D; Lecron JC
Eur Cytokine Netw; 2001; 12(4):639-46. PubMed ID: 11781191
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
35. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gp130 signaling.
Zhang P; Chebath J; Lonai P; Revel M
Stem Cells; 2004; 22(3):344-54. PubMed ID: 15153611
[TBL] [Abstract][Full Text] [Related]
37. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
[TBL] [Abstract][Full Text] [Related]
38. Viral IL-6-induced cell proliferation and immune evasion of interferon activity.
Chatterjee M; Osborne J; Bestetti G; Chang Y; Moore PS
Science; 2002 Nov; 298(5597):1432-5. PubMed ID: 12434062
[TBL] [Abstract][Full Text] [Related]
39. Expression of leukemia inhibitory factor receptor and gp130 in mouse uterus during early pregnancy.
Ni H; Ding NZ; Harper MJ; Yang ZM
Mol Reprod Dev; 2002 Oct; 63(2):143-50. PubMed ID: 12203823
[TBL] [Abstract][Full Text] [Related]
40. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
